PROGRESSIVE PULMONARY FIBROSIS
Clinical trials for PROGRESSIVE PULMONARY FIBROSIS explained in plain language.
Never miss a new study
Get alerted when new PROGRESSIVE PULMONARY FIBROSIS trials appear
Sign up with your email to follow new studies for PROGRESSIVE PULMONARY FIBROSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Inhaled drug shows promise for lung scarring in Long-Term safety trial
Disease control ENROLLING_BY_INVITATIONThis study looks at the long-term safety of an inhaled medication called treprostinil for people with lung scarring conditions like idiopathic pulmonary fibrosis (IPF) or progressive pulmonary fibrosis (PPF). About 1,850 adults who have already taken part in a related study will …
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: United Therapeutics • Aim: Disease control
Last updated May 17, 2026 08:52 UTC
-
New drug aims to slow lung scarring in progressive pulmonary fibrosis
Disease control OngoingThis phase 3 study tests an experimental drug (BMS-986278) in about 1057 adults with progressive pulmonary fibrosis, a condition where lung scarring worsens over time. Participants receive either the drug or a placebo to see if it safely slows disease progression and improves lun…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated May 05, 2026 11:56 UTC
-
New MRI technique could reveal how lung scarring medicines really work
Knowledge-focused OngoingThis study at Duke University is testing whether a special type of MRI (using xenon gas) can show how well antifibrotic medicines are working in people with progressive lung scarring. About 60 adults with interstitial lung disease will get this MRI before starting treatment and a…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Phase: PHASE2 • Sponsor: Duke University • Aim: Knowledge-focused
Last updated May 17, 2026 08:54 UTC
-
Gene hunt: can DNA predict lung disease progression?
Knowledge-focused OngoingThis study follows 250 adults with inherited forms of pulmonary fibrosis to see how their genes influence the speed of lung decline. Participants undergo regular breathing tests and genetic analysis, but no new treatments are tested. The goal is to better understand why some peop…
Matched conditions: PROGRESSIVE PULMONARY FIBROSIS
Sponsor: Istituto Clinico Humanitas • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC